 Reperfusion adjunctive therapy beneficial effects coronary thrombolytic therapy certain adjunctive therapies proven value benefit spite theoretical advantages clinical trials Acetylsalicylic mortality reduction thrombolytic therapy strong theoretical rationale use heparin evidence benefit exists small angiographic trials clinical benefit Early intravenous beta-blockers prethrombolysis era modest benefit extensive data adjuvant use thrombolysis available trial Intravenous nitrates mortality prethrombolysis era trials thrombolytic therapy calcium channel blockers spite variety theoretical benefits value subacute setting diltiazem benefit subgroup patients non-O-wave infarction Angiotensin-converting enzyme inhibitors likely value survivors acute myocardial infarction left ventricular dysfunction benefits acute use experimental infarction clinical trials